查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
寡核甘酸合成市場:各寡核?酸長度，各用途，各類別，各類型，各產品，各地區預測 - 附執行指南(2024年～2028年)
市場調查報告書
商品編碼
1505240

寡核甘酸合成市場:各寡核?酸長度，各用途，各類別，各類型，各產品，各地區預測 - 附執行指南(2024年～2028年)

Oligonucleotide Synthesis Markets. Forecasts by Oligo Length, Application, Category, Type, Product, and Region. With Executive and Consultant Guides. 2024 to 2028
出版日期: | 出版商: Howe Sound Research | 英文 402 Pages | 商品交期: 最快1-2個工作天內

價格

隨著基因技術成為醫療保健、食品生產甚至資料儲存領域的主流，合成寡核?酸有望爆炸性成長。合成 DNA 允許對藻類等生物體進行“客製化設計”，以利用很少的資源生產食物和藥品。 寡核?酸已經在成熟市場和新興市場努力工作。可能性和市場成長是無限的。

本報告提供全球寡核甘酸合成市場相關調查，提供市場概要，以及各寡核?酸長度，各用途，各類別，各類型，各產品，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場指南

第2章 簡介和市場定義

  • 寡核甘酸合成是什麼嗎
  • 市場定義
  • 調查手法
  • 觀點:醫療保健和IVD產業

第3章 寡核甘酸合成

  • 合成技術
  • 自動化
  • 寡核甘酸的種類
  • PCR底層塗料
  • PCR化驗和面板
  • 定序
  • DNA微陣列
  • 螢光原位雜合反應(FISH)
  • 反義寡核甘酸
  • 寡核甘酸的其他的用途
  • CRISPR與遺傳基因編輯的關係

第4章 產業概要

第5章 市場要素

  • 成長促進因素
  • 阻礙成長的要素
  • 今後5年

第6章 寡核甘酸合成的最近趨勢

第7章 主要企業概要

  • Abbott Laboratories
  • Agilent
  • Ajinomoto Bio-Pharma
  • Amyris
  • Ansa BioTechnologies
  • ATG:biosynthetics
  • ATUM
  • Azenta
  • Bayer
  • Beckman Coulter Diagnostics(Danaher)
  • Becton, Dickinson and Company
  • Biogen
  • Biolytic Lab Performance
  • Biomatik
  • bioMerieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Biospring
  • Bio-Synthesis
  • Biotage
  • Blue Heron Biotechnology(Eurofins Genomic)
  • Camena Bioscience
  • Cepheid(Danaher)
  • Chemgenes
  • Codexis
  • Cytena
  • Diasorin S.p.A.
  • DNA Script
  • Enzo Biochem
  • Eurofins Scientific
  • Eurogentec(Kaneka)
  • Evonetix
  • FASMAC
  • GE Healthcare
  • Genomatica
  • Genscript Biotech
  • Glycogene Inc.
  • Hologic
  • Hongene Biotech
  • Innovassynth
  • Integrated DNA Technologies(Danaher)
  • Ionis Pharmaceuticals
  • J&J Innovative Medicine
  • Kern Systems
  • LGC Biosearch Technologies
  • Macrogen
  • Maravai LifeSciences Holdings
  • Merck & Co., Inc
  • Microsynth
  • Millipore Sigma
  • Molecular Assemblies
  • New England Biolabs, Inc.
  • Nippon Shinyaku
  • Nitto Denko(Avecia)
  • Nuclera
  • 寡核?酸 Factory
  • Panagene
  • Primerdesign(Novacyt)
  • Qiagen
  • Revvity
  • Roche Diagnostics
  • Seegene
  • Siemens Healthineers
  • Synthego
  • TAG Copenhagen A/S
  • Thermo Fisher Scientific
  • Twist Bioscience

第8章 寡核甘酸合成的全球市場概要

  • 各國全球市場概要
  • 不同長度全球市場規模- 概要
  • 各用途全球市場規模- 概要
  • 各產品全球市場規模- 概要
  • 各類別全球市場規模- 概要
  • 各類型全球市場規模- 概要

第9章 不同長度全球市場

  • 不滿20mer
  • 21～50mer
  • 51～100mer
  • 超100mer

第10章 各用途全球市場

  • 研究市場
  • 診斷市場
  • 治療市場
  • 資料市場

第11章 各產品全球市場

  • 寡核甘酸市場
  • 設備市場
  • 核甘市場
  • 其他

第12章 各類別全球市場

  • 入門市場
  • 探針市場
  • DNA市場
  • RNA市場
  • 其他

第13章 各類型全球市場

  • 標準寡核甘酸市場
  • 自訂寡核甘酸市場

第14章 附錄

OVERVIEW:

Synthetic Oligonucleotides are poised for explosive growth as gene technology moves into mainstream healthcare, food production and, even, data storage. With Synthetic DNA, organisms, like algae, are "custom designed" to produce food and medicine while consuming few resources. "Oligos" are already hard at work in both mature and emerging market segments. The possibilities, and market growth are unlimited. Our analysis shows that investors do not yet understand the scope of this technology and the enormous market opportunity. Small biotechs could become huge multinationals, all based on producing DNA and its building blocks. Learn all about it and see our forecasts in this comprehensive report.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity. The technology is moving fast. It is coming out of the lab and onto the desktop as genomics itself crosses the chasm.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

  • 2.1. What is Oligonucleotide Synthesis?
    • 2.1.1. The Enzyme Race
    • 2.1.2. Data Storage - The Elephant in the Room
  • 2.2. Market Definition
    • 2.2.1. Market Size
    • 2.2.2. Currency
    • 2.2.3. Years
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Oligonucleotide Synthesis

  • 3.1. Synthesis Technology
  • 3.2. Automation
  • 3.3. Types of Oligonucleotides
  • 3.4. PCR Primers
  • 3.5. PCR Assays and Panels
  • 3.6. Sequencing
  • 3.7. DNA Microarrays
  • 3.8. Fluorescence In Situ Hybridization (FISH)
  • 3.9. Antisense Oligonucleotides
  • 3.10. Other Uses of Oligonucleotides
  • 3.11. Relationship to CRISPR and Gene Editing

4. Industry Overview

  • 4.1. Players in a Dynamic Market
    • 4.1.1. Academic Research Lab
    • 4.1.2. Diagnostic Test Developer
    • 4.1.3. Instrumentation Supplier
    • 4.1.4. Chemical/Reagent Supplier
    • 4.1.5. Pathology Supplier
    • 4.1.6. Independent Clinical Laboratory
    • 4.1.7. Public National/regional Laboratory
    • 4.1.8. Hospital Laboratory
    • 4.1.9. Physicians Office Lab (POLS)
    • 4.1.10. Audit Body
    • 4.1.11. Certification Body

5. Market Factors

  • 5.1. Factors Driving Growth
    • 5.1.1. The Role of Diagnostics and the Covid Effect
    • 5.1.2. The RNA Based Vaccine
    • 5.1.3. Genomic Blizzard
    • 5.1.4. Antisense Revival
    • 5.1.5. New Applications
  • 5.2. Factors Limiting Growth
    • 5.2.1. Declining Price
    • 5.2.2. Technology Lag
    • 5.2.3. COVID Realignment
  • 5.3. The Next Five Years

6. Oligonucleotide Synthesis Recent Developments

  • 6.1. Recent Developments - Importance and How to Use This Section
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. Codexis Successfully Uses Enzymatic Synthesis
  • 6.3. Oligo Factory Achieves GMP Compliance
  • 6.4. Oligonucleotide Synthesis Scaled Up
  • 6.5. Antisense Oligonucleotide Lowers Tau Tangles
  • 6.6. Ansa Biotechnologies Synthesizes Longest Oligo at 1005 Bases
  • 6.7. Agilent will double oligonucleotide capacity
  • 6.8. RNA Synthesis Technology Commercialized by EnPlusOne
  • 6.9. Quick and Automated Printing of Custom Oligos
  • 6.10. WuXi STA Opens Large-Scale Oligo Manufacturing Facility
  • 6.11. Secarna Pharmaceuticals' and Evotec Achieve Programme Designation
  • 6.12. Aligos Discontinues Development of its Antisense Oligonucleotide
  • 6.13. Seegene Obtains CE Mark for Oligo Based SARS-CoV-2 Assay
  • 6.14. Biofidelity to Launch Mutation Detection Assay
  • 6.15. Oligonucleotide Therapeutics Society Holds Meeting
  • 6.16. New Oligonucleotide Synthesis Chemistry
  • 6.17. Antisense Oligonucleotides Cross Rodents' Blood-Brain Barrier
  • 6.18. New Rapid Multiplexed PCR Assay Uses Oligo Probes
  • 6.19. MIT Devises Oligo 'File System' for DNA Data Storage
  • 6.20. Nuclera Acquires E Ink Digital Microfluidics Business
  • 6.21. Twist Bioscience Hits Milestone for DNA Data Storage
  • 6.22. Twist Bioscience, Vivlion Partner on RNA Libraries for CRISPR
  • 6.23. DNA Script Launching Benchtop Synthesizer for 'DNA on Demand'
  • 6.24. RNA Disease Dx to Develop PoC Covid Test
  • 6.25. Evonetix and Analog Devices Develop GEN3 DNA Synthesis Platform
  • 6.26. ATDBio Receives Grant for Cancer Diagnosis Project
  • 6.27. Twist Bioscience Announces Therapeutic Ab
  • 6.28. Drugmakers boost oligo capacity amid Covid-19
  • 6.29. Aligos Therapeutics in Study of Oligo Candidate
  • 6.30. DNA Script Raises $89M for SYNTAX Launch
  • 6.31. Codexis & Molecular Assemblies Partner for DNA Synthesis
  • 6.32. NuProbe Licenses Oligo Technology from Rice
  • 6.33. Genome editing with Cas9-oligo conjugates
  • 6.34. OliX Pharma and AM Chemicals Partner for RNA Synthesis Support
  • 6.35. Twist Bio To End Trade Secrets Suit
  • 6.36. DNA Script, partners get grant for data storage
  • 6.37. Xi's STA unit opens oligonucleotide plant

7. Profiles of Key Companies

  • 7.1. Abbott Laboratories
  • 7.2. Agilent
  • 7.3. Ajinomoto Bio-Pharma
  • 7.4. Amyris
  • 7.5. Ansa BioTechnologies
  • 7.6. ATG:biosynthetics
  • 7.7. ATUM
  • 7.8. Azenta
  • 7.9. Bayer
  • 7.10. Beckman Coulter Diagnostics (Danaher)
  • 7.11. Becton, Dickinson and Company
  • 7.12. Biogen
  • 7.13. Biolytic Lab Performance
  • 7.14. Biomatik
  • 7.15. bioMerieux Diagnostics
  • 7.16. Bioneer Corporation
  • 7.17. Bio-Rad Laboratories, Inc.
  • 7.18. Biospring
  • 7.19. Bio-Synthesis
  • 7.20. Biotage
  • 7.21. Blue Heron Biotechnology (Eurofins Genomic)
  • 7.22. Camena Bioscience
  • 7.23. Cepheid (Danaher)
  • 7.24. Chemgenes
  • 7.25. Codexis
  • 7.26. Cytena
  • 7.27. Diasorin S.p.A.
  • 7.28. DNA Script
  • 7.29. Enzo Biochem
  • 7.30. Eurofins Scientific
  • 7.31. Eurogentec (Kaneka)
  • 7.32. Evonetix
  • 7.33. FASMAC
  • 7.34. GE Healthcare
  • 7.35. Genomatica
  • 7.36. Genscript Biotech
  • 7.37. Glycogene Inc.
  • 7.38. Hologic
  • 7.39. Hongene Biotech
  • 7.40. Innovassynth
  • 7.41. Integrated DNA Technologies (Danaher)
  • 7.42. Ionis Pharmaceuticals
  • 7.43. J&J Innovative Medicine
  • 7.44. Kern Systems
  • 7.45. LGC Biosearch Technologies
  • 7.46. Macrogen
  • 7.47. Maravai LifeSciences Holdings
  • 7.48. Merck & Co., Inc
  • 7.49. Microsynth
  • 7.50. Millipore Sigma
  • 7.51. Molecular Assemblies
  • 7.52. New England Biolabs, Inc.
  • 7.53. Nippon Shinyaku
  • 7.54. Nitto Denko (Avecia)
  • 7.55. Nuclera
  • 7.56. Oligo Factory
  • 7.57. Panagene
  • 7.58. Primerdesign (Novacyt)
  • 7.59. Qiagen
  • 7.60. Revvity
  • 7.61. Roche Diagnostics
  • 7.62. Seegene
  • 7.63. Siemens Healthineers
  • 7.64. Synthego
  • 7.65. TAG Copenhagen A/S
  • 7.66. Thermo Fisher Scientific
  • 7.67. Twist Bioscience

8. Oligonucleotide Synthesis Global Market Overview

  • 8.1. Global Market Overview by Country
    • 8.1.1. Table - Global Market by Country
    • 8.1.2. Chart - Global Market by Country
  • 8.2. Global Market Size by Length - Overview
    • 8.2.1. Table - Global Market by Length
    • 8.2.2. Chart - Global Market by Length - Base/Final Year Comparison
    • 8.2.3. Chart - Global Market by Length - Base Year
    • 8.2.4. Chart - Global Market by Length - Final Year
    • 8.2.5. Chart - Global Market by Length - Share by Year
    • 8.2.6. Chart - Global Market by Length - Segment Growth
  • 8.3. Global Market Size by Application - Overview
    • 8.3.1. Table - Global Market by Application
    • 8.3.2. Chart - Global Market by Application - Base/Final Year Comparison
    • 8.3.3. Chart - Global Market by Application - Base Year
    • 8.3.4. Chart - Global Market by Application - Final Year
    • 8.3.5. Chart - Global Market by Application - Share by Year
    • 8.3.6. Chart - Global Market by Application - Segment Growth
  • 8.4. Global Market Size by Product - Overview
    • 8.4.1. Table - Global Market by Product
    • 8.4.2. Chart - Global Market by Product - Base/Final Year Comparison
    • 8.4.3. Chart - Global Market by Product - Base Year
    • 8.4.4. Chart - Global Market by Product - Final Year
    • 8.4.5. Chart - Global Market by Product - Share by Year
    • 8.4.6. Chart - Global Market by Product - Segment Growth
  • 8.5. Global Market Size by Category - Overview
    • 8.5.1. Table - Global Market by Category
    • 8.5.2. Chart - Global Market by Category - Base/Final Year Comparison
    • 8.5.3. Chart - Global Market by Category - Base Year
    • 8.5.4. Chart - Global Market by Category - Final Year
    • 8.5.5. Chart - Global Market by Category - Share by Year
    • 8.5.6. Chart - Global Market by Category - Segment Growth
  • 8.6. Global Market Size by Type - Overview
    • 8.6.1. Table - Global Market by Type
    • 8.6.2. Chart - Global Market by Type - Base/Final Year Comparison
    • 8.6.3. Chart - Global Market by Type - Base Year
    • 8.6.4. Chart - Global Market by Type - Final Year
    • 8.6.5. Chart - Global Market by Type - Share by Year
    • 8.6.6. Chart - Global Market by Type - Segment Growth

9. Global Market by Length

  • 9.1 <20 mer Market
    • 9.1.1. Table - <20 mer Market by Country
    • 9.1.2. Chart - <20 mer Market Segment Growth
  • 9.2 21-50 mer Market
    • 9.2.1. Table - 21-50 mer Market by Country
    • 9.2.2. Chart - 21-50 mer Market Segment Growth
  • 9.3 51-100 mer Market
    • 9.3.1. Table - 51-100 mer Market by Country
    • 9.3.2. Chart - 51-100 mer Market Segment Growth
  • 9.4 >100 mer Market
    • 9.4.1. Table - >100 mer Market by Country
    • 9.4.2. Chart - >100 mer Market Segment Growth

10. Global Market by Application

  • 10.1. Research Market
    • 10.1.1. Table - Research Market by Country
    • 10.1.2. Chart - Research Market Segment Growth
  • 10.2. Diagnostics Market
    • 10.2.1. Table - Diagnostics Market by Country
    • 10.2.2. Chart - Diagnostics Market Segment Growth
  • 10.3. Therapeutics Market
    • 10.3.1. Table - Therapeutics Market by Country
    • 10.3.2. Chart - Therapeutics Market Segment Growth
  • 10.4. Data Market
    • 10.4.1. Table - Data Market by Country
    • 10.4.2. Chart - Data Market Segment Growth

11. Global Market by Product

  • 11.1. Oligonucleotides Market
    • 11.1.1. Table - Oligonucleotides Market by Country
    • 11.1.2. Chart - Oligonucleotides Market Segment Growth
  • 11.2. Instruments Market
    • 11.2.1. Table - Instruments Market by Country
    • 11.2.2. Chart - Instruments Market Segment Growth
  • 11.3. Nucleosides Market
    • 11.3.1. Table - Nucleosides Market by Country
    • 11.3.2. Chart - Nucleosides Market Segment Growth
  • 11.4. Other Reagents Market
    • 11.4.1. Table - Other Reagents Market by Country
    • 11.4.2. Chart - Other Reagents Market Segment Growth

12. Global Market by Category

  • 12.1. Primer Market
    • 12.1.1. Table - Primer Market by Country
    • 12.1.2. Chart - Primer Market Segment Growth
  • 12.2. Probe Market
    • 12.2.1. Table - Probe Market by Country
    • 12.2.2. Chart - Probe Market Segment Growth
  • 12.3. DNA Market
    • 12.3.1. Table - DNA Market by Country
    • 12.3.2. Chart - DNA Market Segment Growth
  • 12.4. RNA Market
    • 12.4.1. Table - RNA Market by Country
    • 12.4.2. Chart - RNA Market Segment Growth
  • 12.5. Other Nucleic Acid Market
    • 12.5.1. Table - Other Nucleic Acid Market by Country
    • 12.5.2. Chart - Other Nucleic Acid Market Segment Growth

13. Global Market by Type

  • 13.1. Standard Oligonucleotides Market
    • 13.1.1. Table - Standard Oligonucleotides Market by Country
    • 13.1.2. Chart - Standard Oligonucleotides Market Segment Growth
  • 13.2. Custom Oligonucleotides Market
    • 13.2.1. Table - Custom Oligonucleotides Market by Country
    • 13.2.2. Chart - Custom Oligonucleotides Market Segment Growth

14. Appendices

  • 14.1. Typical Oligo Synthesis Price Lists
  • 14.2. Medicare Clinical Lab Fee Schedule
  • 14.3. Drug Approvals by Molecule Type - A Seven Year View
  • 14.4. Growth of Approved IVD Test Menu
  • 14.5. Growth of Approved Average IVD Test Fee
  • 14.6. Share of Pharma R&D by Country

Table of Tables

  • Table 1: Companies Formed to Exploit Enzyme Synthesis
  • Table 2: Market Players by Type
  • Table 3: Five Factors Driving Growth
  • Table 4: Three Factors Limiting Growth
  • Table 5: Global Market by Country/Region
  • Table 6: Global Market by Length
  • Table 7: Global Market by Application
  • Table 8: Global Market by Product
  • Table 9: Global Market by Category
  • Table 10: Global Market by Type
  • Table 11: <20 mer Market by Country
  • Table 12: 21-50 mer Market by Country
  • Table 13: 51-100 mer Market by Country
  • Table 14: >100 mer Market by Country
  • Table 15: Research Market by Country
  • Table 16: Diagnostics Market by Country
  • Table 17: Therapeutics Market by Country
  • Table 18: Data Market by Country
  • Table 19: Oligonucleotides Market by Country
  • Table 20: Instruments Market by Country
  • Table 21: Nucleosides Market by Country
  • Table 22: Other Reagents Market by Country
  • Table 23: Primer Market by Country
  • Table 24: Probe Market by Country
  • Table 25: DNA Market by Country
  • Table 26: RNA Market by Country
  • Table 27: Other Nucleic Acid Market by Country
  • Table 28: Standard Oligonucleotides Market by Country
  • Table 29: Custom Oligonucleotides Market by Country
  • Table 30: Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Global Health Spending
  • Figure 2: The Lab Test Pie
  • Figure 3: Phosphoramidites Structure
  • Figure 4: DNA/Oligonucleotide Synthetic Cycle
  • Figure 5: The Road to Diagnostics
  • Figure 6: Growth rates of Oligionucleotide Synthesis by Application
  • Figure 7: Market Size by Country
  • Figure 8: Global Market by Length - Base vs. Final Year
  • Figure 9: Length Market Base Year
  • Figure 10: Length Market Final Year
  • Figure 11: Length Share by Year
  • Figure 12: Length Segment Growth
  • Figure 13: Global Market by Application - Base vs. Final Year
  • Figure 14: Application Market Base Year
  • Figure 15: Application Market Final Year
  • Figure 16: Application Share by Year
  • Figure 17: Application Segment Growth
  • Figure 18: Global Market by Product - Base vs. Final Year
  • Figure 19: Product Market Base Year
  • Figure 20: Product Market Final Year
  • Figure 21: Product Share by Year
  • Figure 22: Product Segment Growth
  • Figure 23: Global Market by Category - Base vs. Final Year
  • Figure 24: Category Market Base Year
  • Figure 25: Category Market Final Year
  • Figure 26: Category Share by Year
  • Figure 27: Category Segment Growth
  • Figure 28: Global Market by Type - Base vs. Final Year
  • Figure 29: Type Market Base Year
  • Figure 30: Type Market Final Year
  • Figure 31: Type Share by Year
  • Figure 32: Type Segment Growth
  • Figure 33: Chart - <20 mer Market Growth
  • Figure 34: Chart 21-50 mer Market Growth
  • Figure 35: Chart - 51-100 mer Market Growth
  • Figure 36: Chart - >100 mer Market Growth
  • Figure 37: Chart Research Market Growth
  • Figure 38: Chart - Diagnostics Market Growth
  • Figure 39: Chart - Therapeutics market Growth
  • Figure 40: Chart - Data Market Growth
  • Figure 41: Chart Oligonucleotides Market Growth
  • Figure 42: Chart - Instruments Market Growth
  • Figure 43: Chart - Nucleosides Market Growth
  • Figure 44: Chart - Other Reagents Market Growth
  • Figure 45: Chart Primer Market Growth
  • Figure 46: Chart - Probe Market Growth
  • Figure 47: Chart - DNA Market Growth
  • Figure 48: Chart - RNA Market Growth
  • Figure 49: Chart - Other Nucleic Acid Market Growth
  • Figure 50: Chart Standard Oligonucleotides Market Growth
  • Figure 51: Chart - Custom Oligonucleotides Market Growth
  • Figure 52: Eurofins Price List
  • Figure 53: Hokkaido System Science Co. Price List
  • Figure 54: Biobasic Price List
  • Figure 55: Seven Years of FDA Approvals
  • Figure 56: IVD Test Menu Growth
  • Figure 57: IVD Test Average Fees - A Ten Year View
  • Figure 58: Share of Pharma R&D by Country